close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar7999Point34
Implied share price

Buy Undervalued by 43684.0%

5% margin of safety What's this?

EV / Revenue
Use Average
PLX
Protalix BioTherapeutics Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
SNY
Sanofi SA (ADR)
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
21728.76 48.12 27840.41 2.16 10.01 7.2
All amounts in millions
from last financial year
         
Implied Share Price $7999.34 $48757.63 $586514.11 $158268.84 $276776.19
Market Cap 1,701 1,229,412 138,201 107,649 100,042
Net Debt -52 20 8,094 4,504 -3,369
Enterprise Value (EV) 1,656 1,229,432 77,815 112,153 96,673
Revenue 34 44 35,957 11,201 13,418
Balance Sheet          
Total Assets 78 58 100,407 22,496 21,787
Total Liabilities 82 56 43,069 11,127 6,116
Shareholders Equity -3 2 57,338 11,369 15,671.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.